iPath Return on Disability ETN
RODI
RODI was delisted on the 20th of December, 2022.
2 hedge funds and large institutions have $1.06M invested in iPath Return on Disability ETN in 2019 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
98% less capital invested
Capital invested by funds: $43.4M → $1.06M (-$42.3M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$41.5M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Barclays
London,
United Kingdom
| $1.06M | -$41.5M | -488,000 | -98% |
|
RODI Hedge Fund Activity: Q4 2019 in Review
2 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in iPath Return on Disability ETN (RODI) for Q4 2019, worth a combined $1.06M — down 98% from $43.4M a quarter earlier.
Fund positioning in RODI was balanced in Q4 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Barclays, cutting an estimated $41.5M.
- 2 institutional investors held iPath Return on Disability ETN (RODI) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $1.06M of iPath Return on Disability ETN stock for Q4 2019, down 98% quarter-over-quarter.
- 0 funds opened new iPath Return on Disability ETN positions in Q4 2019 and 0 closed out.
- The largest iPath Return on Disability ETN seller in Q4 2019 was Barclays, an estimated $41.5M sold.
Based on aggregated 13F filings for Q4 2019.